HIP1402

DRUG4 trials

Sponsors

Hanmi Pharmaceutical Company Limited

Conditions

Erectile DysfunctionHealthyProstatic Hyperplasia

Phase 1

Investigating the Pharmacokinetic Characteristics of HIP1402 in Healthy Male Volunteers

CompletedNCT02529800

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2015-09-30End: 2015-10-31Updated: 2016-10-13

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

CompletedNCT02712411

Hanmi Pharmaceutical Company LimitedErectile Dysfunction, Prostatic Hyperplasia

Start: 2015-07-31End: 2015-09-30Updated: 2016-03-18

PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

CompletedNCT02715401

Hanmi Pharmaceutical Company LimitedErectile Dysfunction, Prostatic Hyperplasia

Start: 2015-10-31End: 2015-11-30Updated: 2016-03-22

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HIP1801 in Healthy Male Subjects.

CompletedNCT04084197

Hanmi Pharmaceutical Company LimitedHealthy

Start: 2018-12-19End: 2019-01-04Updated: 2019-09-10

Related Papers

Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers

Translational and Clinical Pharmacology2020-01-014 citations